Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)

NCT01024998 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Degeneration
Age-Related Maculopathies
Age-Related Maculopathy
Maculopathies, Age-Related
Maculopathy, Age-Related
Retinal Degeneration
Retinal Neovascularization
Gene Therapy
Therapy, Gene
Eye Diseases

Interventions

BIOLOGICAL: AAV2-sFLT01
BIOLOGICAL: AAV2-sFLT01
BIOLOGICAL: AAV2-sFLT01
BIOLOGICAL: AAV2-sFLT01

Sponsor

Genzyme, a Sanofi Company